Skip to main navigation
Skip to search
Skip to main content
The Capital Region of Denmark's Research Portal Home
Dansk
English
Search content at The Capital Region of Denmark's Research Portal
Home
Hospitals/Departments
Researchers
Research output
Activities
Prizes
Ergocalciferol treatment and aspects of mineral homeostasis in patients with chronic kidney disease stage 4-5
Eva Gravesen
, Jacob Hofman-Bang
, Ewa Lewin
, Klaus Olgaard
Department of Nephrology
31
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Ergocalciferol treatment and aspects of mineral homeostasis in patients with chronic kidney disease stage 4-5'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Mineral Homeostasis
100%
Chronic Kidney Disease Stage
100%
Ergocalciferol
100%
Chronic Kidney Disease
66%
Chronic Kidney Disease Patient
66%
Cardiovascular Mortality
33%
Treatment Side Effects
33%
Treatment Effect
33%
High Dose
33%
Outcome Mortality
33%
Epidemiological Study
33%
Calcitriol
33%
Fibroblast Growth Factor 23 (FGF23)
33%
Adverse Outcomes
33%
Non-classical Effects
33%
Non-dialysis Chronic Kidney Disease
33%
25(OH) Vitamin D
33%
1,25(OH)2 Vitamin D
33%
Nutritional Vitamin D
33%
Vitamin D2
33%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
100%
Ergocalciferol
100%
Vitamin D
40%
Cardiovascular Mortality
20%
Fibroblast Growth Factor 23
20%
Calcitriol
20%
Adverse Outcome
20%
Side Effect
20%